Mera Pharmaceuticals (MRPI) Stock Statistics & Valuation Metrics

Mera Pharmaceuticals has a market cap or net worth of $537.00. The enterprise value is $279.00.

Mera Pharmaceuticals has 536,654,050 shares outstanding. The number of shares has decreased by -2.65% in one year.

Mera Pharmaceuticals’s return on equity (ROE) is 0.19 and return on invested capital (ROIC) is 18.75%.

The current PE Ratio of Mera Pharmaceuticals is ―. Mera Pharmaceuticals’s PEG ratio is 0.00.

In the last 12 months, Mera Pharmaceuticals had revenue of 0.00 and earned ― in profits. Earnings per share was 0.00.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

Mera Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―

Mera Pharmaceuticals upcoming earnings date is ―, ―.

Mera Pharmaceuticals as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, Mera Pharmaceuticals has paid 0.00 in taxes.

Mera Pharmaceuticals EV to EBITDA ratio is 0.00, with an EV/FCF ratio of 0.00.

Mera Pharmaceuticals has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for Mera Pharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―